Autopsy report · NCT04346329

Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19

“The study did not get financed. Never got started.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Universidad Nacional de Colombia

Sponsor type

University, hospital or other

Conditions

COVID

Interventions

Hydroxychloroquine; Placebo oral tablet

Participants

0

Sites

2

Countries

Colombia

Trials that died the same way

• Angiotensin 2 for Hepatorenal Syndrome
  “Funding issues; the study was never started” (87% match in meaning)
• Adenomyosis: Genomic Mechanisms and Biological Response
  “The study never got funded so never started enrolling” (84% match in meaning)
• Treating Wheezing in Children With Hypertonic Saline (TWICS)
  “Funding declined. Study never initiated.” (84% match in meaning)
• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (82% match in meaning)
• GO-203-2C + Bortezomib For Relapsed Or Refractory MM
  “Study was never open due to lack of funding” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.